Oral Anticoagulants Market 2022
Anticoagulant is a drug, when added to blood, prevents it from clotting. Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood. Such drugs are often used to prevent the formation of blood clots (thrombi) in the veins or arteries or the enlargement of a clot that is circulating in the bloodstream.
The Global Oral Anticoagulants Market Size is expected to grow at CAGR of 12.50% to reach USD 22,561.24 million by Forecast.
Increasing cardiovascular disorders, rising geriatric population, and increasing surgical procedures support the growth of the global Oral Anticoagulants Market in recent years. However, the high cost is likely to restrain market growth over the forecast period.
Major Key Players:
Market Research Future (MRFR) recognizes the following companies as the key players in the global Oral Anticoagulants Market Size that includes AstraZeneca, Plc (UK), Pfizer (US), Boehringer Ingelheim GmbH (Germany), Daiichi Sankyo Company Ltd (Japan), Abbott Laboratories (US), Eli Lilly and Company (US), GlaxoSmithKline plc (UK) Portola Pharmaceuticals Inc. (US), Medicure (Canada), Johnson & Johnson Services Inc. (US), and others.
The global oral anticoagulants market has been segmented into product, disease indication, distribution channel, and region. Based on product, the injectable anticoagulants and oral anticoagulants market has been segmented into novel oral anticoagulant and warfarin. On the basis of disease indication, the global oral anticoagulants market has been segmented into atrial fibrillation (AF)/ stroke prevention and deep vein thrombosis/ pulmonary embolism, and others. On the basis of distribution channel, the global oral anticoagulants market has been segmented into hospital pharmacies, retail pharmacies, and E-commerce.
Geographically, the Americas is expected to dominate the global Oral Anticoagulants Market Size. This is owing to increasing cardiovascular disorders and increasing surgical procedures. Europe showed a considerable amount of growth in the market due to the rising geriatric population. Asia-Pacific is estimated to be the fastest growing region in the market. This is owing to increasing cardiovascular disorders and rising geriatric population. On the other hand, the Middle East & Africa has the least share of the market.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312